Live Breaking News & Updates on Clinical Trials Arena

Stay updated with breaking news from Clinical trials arena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ASCO 24: Data shows survival benefit with J&J's subcutaneous Rybrevant

J&J's Rybrevant is expected to generate $4bn in sales by 2030, as per GlobalData estimates. ....

United States , Astrazeneca Tagrisso , European Medicines Agency , American Society Of Clinical Oncology , American Society , Clinical Oncology , Annual Meeting , Johnson Innovative Medicine , Biologics License Application , Clinical Trials Arena ,

Apellis and Sobi report data from Phase II C3 glomerulopathy trial

Pegcetacoplan treatment resulted in sustained improvements in proteinuria and kidney function stabilisation. ....

Caroline Baumal , Apellis Pharmaceuticals , Clinical Trials Arena ,

Novartis' atrasentan shows to reduce proteinuria in Phase III IgAN trial

Atrasentan’s safety profile in the trial was deemed favourable, aligning with previous data. ....

David Soergel , Metabolism Development Unit , Drug Administration , Clinical Trials Arena ,

Imvax concludes enrolment in Phase IIb glioblastoma treatment trial

The company secured $35m in financing to support IGV-001’s clinical development. ....

John Furey , Drug Administration , Clinical Trials Arena ,

Eli Lilly's mirikizumab shows promise in Phase III Crohn's disease trial

Mirikizumab demonstrated significant improvements in Crohn's disease patients. ....

Eli Lilly , Mark Genovese , Drug Administration , European Medicines Agency , Lilly Immunology , Clinical Trials Arena ,